Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys.

Wallace BA, Ashkan K, Heise CE, Foote KD, Torres N, Mitrofanis J, Benabid AL.

Brain. 2007 Aug;130(Pt 8):2129-45. Epub 2007 Jun 20.

2.

Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus.

Shaw VE, Keay KA, Ashkan K, Benabid AL, Mitrofanis J.

Parkinsonism Relat Disord. 2010 Jun;16(5):338-44. doi: 10.1016/j.parkreldis.2010.02.008. Epub 2010 Mar 12.

PMID:
20227323
3.

Does increased excitatory drive from the subthalamic nucleus contribute to dopaminergic neuronal death in Parkinson's disease?

Luquin MR, Saldise L, Guillén J, Belzunegui S, San Sebastián W, Izal A, Garrido P, Vázquez M.

Exp Neurol. 2006 Oct;201(2):407-15. Epub 2006 Jun 27.

PMID:
16806173
4.

Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment.

Shaw VE, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J.

J Comp Neurol. 2010 Jan 1;518(1):25-40. doi: 10.1002/cne.22207.

PMID:
19882716
5.

Does melatonin help save dopaminergic cells in MPTP-treated mice?

Ma J, Shaw VE, Mitrofanis J.

Parkinsonism Relat Disord. 2009 May;15(4):307-14. doi: 10.1016/j.parkreldis.2008.07.008. Epub 2008 Sep 14.

PMID:
18793863
6.

Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?

Herrero MT, Hirsch EC, Kastner A, Ruberg M, Luquin MR, Laguna J, Javoy-Agid F, Obeso JA, Agid Y.

Neuroscience. 1993 Sep;56(2):499-511.

PMID:
8247275
7.

Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.

Albanese A, Granata R, Gregori B, Piccardi MP, Colosimo C, Tonali P.

Neuroscience. 1993 Aug;55(3):823-32.

PMID:
8105418
8.
9.
10.

Differential survival patterns among midbrain dopaminergic cells of MPTP-treated monkeys and 6OHDA-lesioned rats.

Fitzpatrick E, Ashkan K, Wallace BA, Benabid AL, Mitrofanis J.

Anat Embryol (Berl). 2005 Sep;210(2):101-23. Epub 2005 Oct 18.

PMID:
16151853
11.

Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat.

Ni Z, Bouali-Benazzouz R, Gao D, Benabid AL, Benazzouz A.

Synapse. 2001 May;40(2):145-53.

PMID:
11252026
12.

GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys.

Herrero MT, Perez-Otaño I, Oset C, Kastner A, Hirsch EC, Agid Y, Luquin MR, Obeso JA, Del Rio J.

Neuroscience. 1993 Oct;56(4):965-72.

PMID:
7904332
14.
15.

Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys.

Vázquez-Claverie M, Garrido-Gil P, San Sebastián W, Izal-Azcárate A, Belzunegui S, Marcilla I, López B, Luquin MR.

J Neuropathol Exp Neurol. 2009 Sep;68(9):977-84. doi: 10.1097/NEN.0b013e3181b35e41.

16.

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys.

Garrido-Gil P, Belzunegui S, San Sebastián W, Izal-Azcárate A, López B, Marcilla I, Luquin MR.

J Neurosci Res. 2009 Feb;87(2):586-97. doi: 10.1002/jnr.21845.

PMID:
18798285
17.

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not elicit long-lasting increases in cyclooxygenase-2 expression in dopaminergic neurons of monkeys.

Vázquez-Claverie M, Garrido-Gil P, San Sebastián W, Belzunegui S, Izal-Azcárate A, López B, Marcilla I, Luquin MR.

J Neuropathol Exp Neurol. 2009 Jan;68(1):26-36. doi: 10.1097/NEN.0b013e3181919275.

18.
19.

Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis.

Guridi J, Herrero MT, Luquin MR, Guillén J, Ruberg M, Laguna J, Vila M, Javoy-Agid F, Agid Y, Hirsch E, Obeso JA.

Brain. 1996 Oct;119 ( Pt 5):1717-27.

20.

Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas.

Marzatico F, Café C, Taborelli M, Benzi G.

Neurochem Res. 1993 Oct;18(10):1101-6.

PMID:
8255359
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk